9886 — Dingdang Health Technology Balance Sheet
0.000.00%
- HK$461.82m
- -HK$651.00m
- CNY4.67bn
- 39
- 74
- 24
- 42
Annual balance sheet for Dingdang Health Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 582 | 1,553 | 1,348 | 1,329 | 1,218 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 165 | 241 | 407 | 323 | 376 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,093 | 2,268 | 2,528 | 2,372 | 2,202 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 198 | 214 | 217 | 194 | 206 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1,786 | 2,946 | 3,297 | 3,065 | 2,633 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 602 | 739 | 969 | 913 | 832 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 3,145 | 5,558 | 1,112 | 1,027 | 972 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | -1,358 | -2,612 | 2,186 | 2,037 | 1,660 |
Total Liabilities & Shareholders' Equity | 1,786 | 2,946 | 3,297 | 3,065 | 2,633 |
Total Common Shares Outstanding |